vs
Astrana Health, Inc.（ASTH）与CALERES INC（CAL）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是CALERES INC的1.2倍（$950.5M vs $790.1M），Astrana Health, Inc.净利率更高（0.7% vs 0.3%，领先0.4%），Astrana Health, Inc.同比增速更快（42.9% vs 6.6%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-12.4M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 6.5%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Caleres Inc是一家美国鞋履企业，旗下拥有并运营多个鞋履品牌，总部坐落于圣路易斯郊区密苏里州克莱顿。该企业前身是1878年在圣路易斯成立的Bryan, Brown & Company，此后历经多次更名，其前身汉密尔顿-布朗鞋业在20世纪初曾是美国最大的鞋履制造商。
ASTH vs CAL — 直观对比
营收规模更大
ASTH
是对方的1.2倍
$790.1M
营收增速更快
ASTH
高出36.3%
6.6%
净利率更高
ASTH
高出0.4%
0.3%
自由现金流更多
ASTH
多$6.4M
$-12.4M
两年增速更快
ASTH
近两年复合增速
6.5%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $790.1M |
| 净利润 | $6.6M | $2.4M |
| 毛利率 | — | 41.8% |
| 营业利润率 | 1.9% | 1.5% |
| 净利率 | 0.7% | 0.3% |
| 营收同比 | 42.9% | 6.6% |
| 净利润同比 | 184.4% | -94.2% |
| 每股收益（稀释后） | $0.12 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHCAL
| Q4 25 | $950.5M | $790.1M | ||
| Q3 25 | $956.0M | $658.5M | ||
| Q2 25 | $654.8M | $614.2M | ||
| Q1 25 | $620.4M | $639.2M | ||
| Q4 24 | $665.2M | $740.9M | ||
| Q3 24 | $478.7M | $683.3M | ||
| Q2 24 | $486.3M | $659.2M | ||
| Q1 24 | $404.4M | $697.1M |
净利润ASTHCAL
| Q4 25 | $6.6M | $2.4M | ||
| Q3 25 | $373.0K | $6.7M | ||
| Q2 25 | $9.4M | $6.9M | ||
| Q1 25 | $6.7M | $4.9M | ||
| Q4 24 | $-7.8M | $41.4M | ||
| Q3 24 | $16.1M | $30.0M | ||
| Q2 24 | $19.2M | $30.9M | ||
| Q1 24 | $14.8M | $55.7M |
毛利率ASTHCAL
| Q4 25 | — | 41.8% | ||
| Q3 25 | — | 43.4% | ||
| Q2 25 | — | 45.4% | ||
| Q1 25 | — | 43.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 45.5% | ||
| Q2 24 | — | 46.9% | ||
| Q1 24 | — | 43.9% |
营业利润率ASTHCAL
| Q4 25 | 1.9% | 1.5% | ||
| Q3 25 | 2.0% | 1.4% | ||
| Q2 25 | 3.1% | 1.9% | ||
| Q1 25 | 3.3% | 1.2% | ||
| Q4 24 | 0.1% | 7.7% | ||
| Q3 24 | 5.9% | 6.2% | ||
| Q2 24 | 6.2% | 6.5% | ||
| Q1 24 | 7.5% | 4.4% |
净利率ASTHCAL
| Q4 25 | 0.7% | 0.3% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | 1.4% | 1.1% | ||
| Q1 25 | 1.1% | 0.8% | ||
| Q4 24 | -1.2% | 5.6% | ||
| Q3 24 | 3.4% | 4.4% | ||
| Q2 24 | 3.9% | 4.7% | ||
| Q1 24 | 3.7% | 8.0% |
每股收益（稀释后）ASTHCAL
| Q4 25 | $0.12 | $0.07 | ||
| Q3 25 | $0.01 | $0.20 | ||
| Q2 25 | $0.19 | $0.21 | ||
| Q1 25 | $0.14 | $0.17 | ||
| Q4 24 | $-0.14 | $1.19 | ||
| Q3 24 | $0.33 | $0.85 | ||
| Q2 24 | $0.40 | $0.88 | ||
| Q1 24 | $0.31 | $1.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $34.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $616.8M |
| 总资产 | $2.2B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHCAL
| Q4 25 | $429.5M | $34.0M | ||
| Q3 25 | $463.4M | $191.5M | ||
| Q2 25 | $342.1M | $33.1M | ||
| Q1 25 | $260.9M | $29.6M | ||
| Q4 24 | $290.8M | $33.7M | ||
| Q3 24 | $350.3M | $51.8M | ||
| Q2 24 | $327.7M | $30.7M | ||
| Q1 24 | $337.3M | $21.4M |
股东权益ASTHCAL
| Q4 25 | $779.3M | $616.8M | ||
| Q3 25 | $775.5M | $613.3M | ||
| Q2 25 | $765.5M | $605.2M | ||
| Q1 25 | $745.4M | $599.0M | ||
| Q4 24 | $712.7M | $598.3M | ||
| Q3 24 | $704.6M | $606.1M | ||
| Q2 24 | $678.9M | $570.3M | ||
| Q1 24 | $653.5M | $560.6M |
总资产ASTHCAL
| Q4 25 | $2.2B | $2.1B | ||
| Q3 25 | $2.2B | $2.2B | ||
| Q2 25 | $1.4B | $1.9B | ||
| Q1 25 | $1.3B | $1.9B | ||
| Q4 24 | $1.4B | $2.0B | ||
| Q3 24 | $1.3B | $2.0B | ||
| Q2 24 | $1.3B | $1.9B | ||
| Q1 24 | $1.2B | $1.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-12.4M |
| 自由现金流率自由现金流/营收 | -0.6% | -1.6% |
| 资本支出强度资本支出/营收 | 0.3% | 1.4% |
| 现金转化率经营现金流/净利润 | -0.44× | -0.50× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $14.4M |
8季度趋势，按日历期对齐
经营现金流ASTHCAL
| Q4 25 | $-2.9M | $-1.2M | ||
| Q3 25 | $10.0M | $47.3M | ||
| Q2 25 | $90.9M | $-5.7M | ||
| Q1 25 | $16.6M | $28.7M | ||
| Q4 24 | $-10.9M | $-39.8M | ||
| Q3 24 | $34.0M | $79.6M | ||
| Q2 24 | $23.2M | $36.1M | ||
| Q1 24 | $6.0M | $43.0M |
自由现金流ASTHCAL
| Q4 25 | $-6.0M | $-12.4M | ||
| Q3 25 | $7.4M | $35.0M | ||
| Q2 25 | $89.5M | $-26.2M | ||
| Q1 25 | $13.6M | $18.0M | ||
| Q4 24 | $-13.5M | $-57.4M | ||
| Q3 24 | $31.7M | $68.5M | ||
| Q2 24 | $20.4M | $26.3M | ||
| Q1 24 | $5.6M | $32.4M |
自由现金流率ASTHCAL
| Q4 25 | -0.6% | -1.6% | ||
| Q3 25 | 0.8% | 5.3% | ||
| Q2 25 | 13.7% | -4.3% | ||
| Q1 25 | 2.2% | 2.8% | ||
| Q4 24 | -2.0% | -7.7% | ||
| Q3 24 | 6.6% | 10.0% | ||
| Q2 24 | 4.2% | 4.0% | ||
| Q1 24 | 1.4% | 4.6% |
资本支出强度ASTHCAL
| Q4 25 | 0.3% | 1.4% | ||
| Q3 25 | 0.3% | 1.9% | ||
| Q2 25 | 0.2% | 3.3% | ||
| Q1 25 | 0.5% | 1.7% | ||
| Q4 24 | 0.4% | 2.4% | ||
| Q3 24 | 0.5% | 1.6% | ||
| Q2 24 | 0.6% | 1.5% | ||
| Q1 24 | 0.1% | 1.5% |
现金转化率ASTHCAL
| Q4 25 | -0.44× | -0.50× | ||
| Q3 25 | 26.69× | 7.05× | ||
| Q2 25 | 9.65× | -0.81× | ||
| Q1 25 | 2.48× | 5.82× | ||
| Q4 24 | — | -0.96× | ||
| Q3 24 | 2.11× | 2.66× | ||
| Q2 24 | 1.21× | 1.17× | ||
| Q1 24 | 0.40× | 0.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CAL
| Brand Portfolio | $383.7M | 49% |
| Landed Wholesale | $148.1M | 19% |
| Wholesale E Commerce | $75.0M | 9% |
| Ecommerce | $68.8M | 9% |
| Stuart Weitzman Brand | $45.8M | 6% |
| Landed Wholesale Ecommerce Drop Ship | $30.6M | 4% |
| First Cost Wholesale | $14.9M | 2% |
| Clt Brand Solutions | $10.2M | 1% |
| License And Royalty | $2.1M | 0% |
